Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

An elderly Chinese man lost all his hair after taking a new heart medication.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Eating grape powder may reduce the severity of skin allergy symptoms.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Upadacitinib may effectively treat alopecia areata without side effects.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Upadacitinib improved multiple immune-related conditions in one patient.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Cancer treatments often cause skin, nail, and hair problems.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.